Investors Tire of A...
Health Care: Drugs
GTC Biotherapeutics Inc (GTCB: OTC)
$0.35 0.05 | 16.67%
12/10/10 - 03:38 PM ET
9.00K / 4.80K
Vol / Avg. Vol:0.29 / 0.30
Open / Prev. Close:0.21 - 0.35
Today's Range:0.21 - 1.66
52 Wk Range:-53.33%
Performance YTD:TheStreet Rating:
Portfolios with GTCB
- Portfolio NameUser Type
- UserSUPRATRADE HOT STOCKS BUY L...
- UserSUPRATRADE HOT STOCKS (BUY ...
- Useratifkhan
- UserDave's Diamond Fund
- UserRebel's Stocks
- Userwalt4803 Portfolio 1
- Userjerk
- UserAZBALLGOFAR*Portfolio 1
- Userrsheedy Portfolio 1
- Usernaureensayani Portfolio 1
Latest GTCB Headlines from TheStreet
- Tuesday's Small-Cap Winners & Losers 09.04.07 | 03:09 pm
- Today's Health Winners and Losers 02.23.06 | 02:02 pm
- Health Stocks in Motion: Possis 08.08.05 | 01:08 pm
- Health Stocks in Motion 01.24.05 | 04:01 pm
Press Releases for GTCB
- GTC Biotherapeutics, Inc., A LFB Group Company, Granted Protection Until 2027 On Broad Transgenic Protein Production Patent, And Is Also Granted New Patent On Recombinant Anti-Thrombin Produced Transgenically - Business Wire 05.20.11 | 08:05 am
- Acquisition Of GTC Biotherapeutics, Inc. By LFB Biotechnologies S.A.S. Completed - Business Wire 12.06.10 | 08:12 am
- GTC Biotherapeutics, Inc. Agrees To Be Taken Private For $.30 Per Share - Business Wire 11.08.10 | 08:11 am
- GTC Biotherapeutics Reports Third Quarter 2010 Financial Results - Business Wire 10.27.10 | 08:10 am
- GTC Biotherapeutics To Host Third Quarter 2010 Earnings Call And Webcast On Wednesday, October 27, 2010 - Business Wire 10.20.10 | 08:10 am
- LFB Biotechnologies, S.A.S. Offers To Take GTC Biotherapeutics, Inc. Private For $.28 Per Share - Business Wire 10.19.10 | 08:10 am
- GTC Biotherapeutics Reports Second Quarter 2010 Financial Results - Business Wire 07.27.10 | 08:07 am
- GTC Biotherapeutics To Host Second Quarter 2010 Earnings Call And Webcast On Tuesday, July 27, 2010 - Business Wire 07.20.10 | 03:07 pm
- GTC Biotherapeutics Regains US Rights To ATryn® ; The First Recombinant Antithrombin Product Approved In The World - Business Wire 07.16.10 | 08:07 am
- GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring And Management Changes - Business Wire 06.16.10 | 08:06 am
Partner Headlines for GTCB
- Risky assets rally as test results digested - Financial Times 07.23.10 | 09:07 pm
